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Edited by Hans EklundAbstract When the inﬂuence of ADP-ribosylation on the activ-
ities of the puriﬁed human glutamate dehydrogenase isozymes
(hGDH1 and hGDH2) was measured in the presence of
100 lM NAD+ for 60 min, hGDH isozymes were inhibited by
up to 75%. If incubations were performed for longer time periods
up to 3 h, the inhibition of hGDH isozymes did not increased fur-
ther. This phenomenon may be related to the reversibility of
ADP-ribosylation in mitochondria. ADP-ribosylated hDGH
isozymes were reactivated by Mg2+-dependent mitochondrial
ADP-ribosylcysteine hydrolase. The stoichiometry between
incorporated ADP-ribose and GDH subunits shows a modiﬁcation
of one subunit per catalytically active homohexamer. Since ADP
and GTP had no eﬀects on the extent of modiﬁcation, it would
appear that the ADP-ribosylation is unlikely to occur in alloste-
ric sites. It has been proposed that Cys residue may be involved
in the ADP-ribosylation of GDH, although identiﬁcation of the
reactive Cys residue has not been reported. To identify the reac-
tive Cys residue involved in the ADP-ribosylation, we performed
cassette mutagenesis at three diﬀerent positions (Cys59, Cys119,
and Cys274) using synthetic genes of hGDH isozymes. Among
the Cys residues tested, only Cys119 mutants showed a signiﬁ-
cant reduction in the ADP-ribosylation. These results suggest
a possibility that the Cys119 residue has an important role in
the regulation of hGDH isozymes by ADP-ribosylation.
 2005 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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Glutamate dehydrogenase (GDH; EC 1.4.1.3) catalyzes the
reversible deamination of L-glutamate to a-ketoglutarate [1].
GDH is diﬀerentially distributed in various catalytically active
isoforms of the enzyme and the presence of diﬀerent size ofAbbreviations: GDH, glutamate dehydrogenase
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doi:10.1016/j.febslet.2005.06.041mRNAs and multiple gene copies for GDH has been reported
[2–6]. hGDH1 (house-keeping GDH) is expressed widely,
whereas hGDH2 (nerve-speciﬁc GDH) is speciﬁc for neural
and testicular tissues [5,7]. hGDH2 is the heat-labile form of
human GDH and highly regulated by ADP [7]. Although
many studies show the subcellular localization of GDH, the
origin of the GDH polymorphism is not fully understood
and the functional signiﬁcance of GDH isozymes remains to
be studied. Most recent study has reported that GLUD2 orig-
inated by retroposition from GLUD1 in the hominoid ancestor
less than 23 million years ago and the amino acid changes
responsible for the unique nerve-speciﬁc properties of the en-
zyme derived from GLUD2 occurred during a period of posi-
tive selection after the duplication event [8]. However, it is
not known whether the distinct properties of the hGDH iso-
zymes are essential for the regulation of glutamate metabolism.
Therefore, further characterization of the function and regula-
tion of human GDH isozymes is needed to elucidate the phys-
iological nature of the GDH-related disorders [4,9,10].
Mammalian GDH is strictly regulated by allosteric regula-
tors such as ADP, L-Leu, and GTP [1,8]. In addition to the
allosteric regulations, GDH has been known to be regulated
by reversible ADP-ribosylation both in vivo and in vitro
[11]. According to the observations, ADP-ribosylation of
GDH led to substantial inhibition of its catalytic activity
and ADP-ribosylated GDH was reactivated by an Mg2+-
dependent mitochondrial ADP-ribosylcysteine hydrolase
[11]. In vivo, monoADP-ribosylation is catalyzed by mono-
ADP-ribosyl transferases, modifying speciﬁc amino acids of
the receptor proteins [12,13]. Although many researchers
have studied ADP-ribozylation of mitochondrial proteins
for almost two decades [11–15], the identity of the proteins
involved remained unknown until Herrero-Yraola et al.
[11] showed that GDH is the actual target of this modiﬁca-
tion. They suggested that GDH was ADP-ribosylated in a
Cys residue in the presence of mitochondrial activity that
transferred the ADP-ribose from NAD+ onto the acceptor
site. The formation of free ADP-ribose from NAD+ and
thus non-enzymatic ADP-ribosylation could be virtually ex-
cluded under well-deﬁned conditions [13–15], permitting the
detection of enzymatic Cys-speciﬁc transfer of ADP-ribose
from NAD+ onto Cys residues of the acceptor proteins in
bovine liver mitochondria [11,13]. These ﬁndings have raisedation of European Biochemical Societies.
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involved in glutamate metabolism regulation.
Chemical modiﬁcation studies can make a useful contribu-
tion, by providing insight into a highly conserved region of the
sequence, and by providing ameans of detecting substrate bind-
ing through protection studies. The only clear consensus emerg-
ing from such studies of GDHs from various sources is that Lys
residues are involved in the active site [16–18]. Cys residues are
another obvious target for modiﬁcation for several reasons.
Their relative infrequency and the availability of reasonably spe-
ciﬁc reagents provide an opportunity for unambiguous modiﬁ-
cation and Cys side-chains are frequently involved in enzyme
catalysis. It has been reported that bovine GDH is inactivated
by o-phthalaldehyde and that Cys and Lys residues are present
at the active site [19–22]. No direct evidence for involvement of
Cys residue(s) in the ADP-ribosylation has been reported yet.
Recently, we have constructed synthetic genes encoding hu-
man GDH isozymes (hGDH1 and hGDH2) and expressed in
Escherichia coli as soluble proteins in our laboratory [23,24].
Using the synthetic hGDH genes, we have identiﬁed reactive
amino acid residues involved in substrate-binding sites
[25,26] and allosteric regulatory sites [27,28] by cassette muta-
genesis. There are six Cys residues at positions of 59, 93, 119,
201, 274, and 323 in both hGDH1 and hGDH2. We have re-
ported that chemical modiﬁcation or site-directed mutagenesis
of Cys323 residue causes a loss of enzyme activity but Cys323
is not involved in ADP-ribosylation [21,22]. In the present
study, therefore, we have performed the cassette mutagenesis
at ﬁve diﬀerent Cys residues (Cys59, Cys93, Cys119, Cys201,
and Cys274) of hGDH isozymes and examined their role in
ADP-ribosylation. To our knowledge, this is the ﬁrst report
showing that Cys119 plays an important role in the regulation
of human GDH isozymes by ADP-ribosylation.2. Materials and methods
2.1. Materials
NADH, 2-oxoglutarate, ADP, GTP, and isopropyl b-D-thiogalacto-
pyranoside (IPTG) were purchased from Sigma Chemical Co. Human
GDH1 and GDH2 genes (pHGDH1 and pHGDH2, respectively) have
been chemically synthesized and expressed in E. coli as soluble proteins
in our laboratory as described elsewhere [23,24]. [32P]NAD+, ADP–Se-
pharose, and Resource-Q were purchased from Amersham Pharmacia
Biotech. Restriction enzymes were purchased from New England Bio-
labs. Pre-stained marker proteins for Western blot were purchased
from NOVEX. Low molecular weight protein marker for SDS/PAGE
was purchased from Bio-Rad. All other chemicals and solvents were
reagent grade or better.
2.2. Bacterial strains
Escherichia coliDH5a [24]was purchased from Invitrogen andused as
the host strain for plasmid-mediated transformations for cassette muta-
genesis.E. coliPA340 (thr-1 fhuA2 leuB6 lacY1 supE44 gal-6 gdh-1 hisG1
rfbD1 galP63 D(gltB-F)500 rpsL19 malT1 xyl-7 mtl-2 argH1 thi-1;
kindly provided by Dr.Mary K.B. Berlyn, E. coliGenetic Stock Center,
Yale University) lacked both GDH and glutamate synthase activities
[29] and was used to test plasmids for GDH activity. E. coli BL21
(DE3) [24] was used for high level expression of the recombinant GDH.
2.3. Construction of mutants
To make hGDH mutant proteins, amino acid substitutions at ﬁve
diﬀerent Cys sites (Cys59, Cys93, Cys119, Cys201, and Cys274) were
constructed by cassette mutagenesis of synthetic hGDH1 gene
(pHGDH1) and hGDH2 gene (pHGDH2) as described elsewhere
[23,24]. Plasmid DNA was digested with restriction enzymes to removethe ﬂanking fragment that encodes target amino acid. The ﬂanking
fragment was replaced with synthetic DNA duplex containing a substi-
tution (Ala, Gly, or Tyr) on both DNA strand at three diﬀerent Cys
sites. Mutagenic oligonucleotides were annealed, ligated, and trans-
formed into DH5a and resultant mutant plasmids were identiﬁed by
DNA sequencing using plasmid DNA as a template. The wild type
and mutant proteins were expressed in E. coli strain DE3 and puriﬁed
to homogeneity, and has had its steady state kinetic parameters deter-
mined as described below. The gene expression level of the mutant pro-
teins was examined by Western blot using monoclonal antibodies
previously produced in our laboratory against the bovine brain
GDH [30].
2.4. Protein puriﬁcation and kinetic studies
Fresh overnight cultures of DE3/pHGDH1 and DE3/pHGDH2
were used to inoculate 1 L of LB containing 100 lg of ampicillin per
ml. DE3/pHGDH was grown at 37 C until the A600 reached 1.0 and
then IPTG was added to a ﬁnal concentration of 1 mM. After IPTG
induction, DE3/pHGDH was grown for an additional 3 h at 37 C
and then harvested by centrifugation. Cell pellets were suspended in
100 ml of 100 mM Tris–HCl, pH 7.4/1 mM EDTA/5 mM dithiothrei-
tol and lysed with a sonicator. Cellular debris was removed by centri-
fugation and GDH was puriﬁed by ADP–Sepharose column followed
by FPLC Resource-Q column as described elsewhere [23]. The puriﬁed
GDH was analyzed by SDS–PAGE.
Steady state kinetic parameters were determined with the puriﬁed
proteins unless otherwise indicated. Since E. coli only has an
NADP+-dependent GDH [29], the enzyme assay was performed with
NADH as a coenzyme. GDH activity was measured spectrophotomet-
rically in the direction of reductive amination of 2-oxoglutarate by fol-
lowing the decrease in absorbance at 340 nm as described before [23].
One unit of enzyme was deﬁned as the amount of enzyme required to
oxidize 1 lmol of NADH per minute at 25 C. For determination of
Km values, the assays were carried out in the presence of 1 mM ADP
unless otherwise indicated by varying the substrate under investigation
while keeping the other substrate and reagents at the optimal concen-
trations. The Km value was calculated by linear regression analysis of
double-reciprocal plots and given along with standard errors. Catalytic
eﬃciency was estimated by use of the equation v/[E0] = (kcat/Km)[S]
[23].
2.5. ADP-ribosylation assays
Bovine liver mitochondria were isolated and washed in 10 mM Tris–
HCl, pH 7.5, 250 mM sucrose, 0.5 mM EDTA as described Herrero-
Yraola et al. [11]. The mitochondrial preparations used for analysis
of ADP-ribosylation were pre-incubated for 15 min with 10 mM
DTT and 2 mM EDTA to prevent cleavage of NAD+ by the NAD+
glycohydrolase [11,13]. ADP-ribosylation of puriﬁed wild-type and
mutant GDHs was investigated by incubating enzymes in the standard
mixture containing 50 mM MOPS–KOH, pH 7.5, 10 mM DTT, and
2 m MEDTA. The reaction was initiated by adding 0.1 mM NAD+
and 10 lg of the preincubated mitochondrial preparations at 30 C.
After incubation at 30 C for the time indicated, aliquots were with-
drawn to measure remaining activities. For the gel electrophoretic
analysis of the ADP-ribosylated enzymes, [32P]NAD+ was used instead
of NAD+ and the reaction was stopped the time indicated by acetone
precipitation. The pellets were re-suspended in sample buﬀer used for
gel electrophoresis. The eﬀect on endogenous GDH activity of the
mitochondrial preparation was investigated using the solublized mito-
chondrial preparations in the presence of 750 mM-aminocapronic
acid, 50 mM Bis–Tris, pH 7.0, and 2% Triton X-100 as described else-
where [11]. Non-enzymatic ADP-ribosylation was studied under the
same conditions with ADP-ribose instead of NAD+.2.6. Incorporation of ADP-ribose into wild-type and mutant GDHs
Puriﬁed wild-type and mutant GDHs were separately ADP-ribosy-
lated in the presence of mitochondrial preparation and 0.1 mM
[32P]NAD+ (10 lCi/ml) under the same conditions as used in ADP-
ribosylation assays. After several time intervals up to 60 min, aliquots
were withdrawn and 5 mM unlabeled NAD+ was added and the mito-
chondria sedimented. The supernatant was subjected to gel ﬁltration
by HPLC with Protein-Pak 300SW column in a 20 mM Tris/HCl,
pH 7.5 containing 200 mM NaCl. Fractions containing GDH (as as-
sayed by Western blot) were pooled and their radioactivity and protein
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from control samples lacking GDH. Data are expressed as the molar
ratio of 32P incorporated per hexameric enzyme.3. Results and discussion
When the inﬂuence of ADP-ribosylation on the activities of
the puriﬁed hGDH isozymes was measured in the presence of
100 lM NAD+ for 60 min, hGDH isozymes were inhibited by
75% and 70% for hGDH1 and hGDH2, respectively (Fig. 1A).
If incubations were performed for longer time periods up to
3 h, the inhibition of hGDH isozymes did not increased fur-
ther. This phenomenon is similar to those reported by other
investigators [11,15], suggesting that a Mg2+-stimulated
ADP-ribosylcysteine hydrolase is present in the mitochondrial
preparation that removes the modiﬁcation from the GDH and
prevents complete inhibition [11]. If modiﬁcations of GDH
isozymes were a regulatory mechanism, both ADP-ribosyla-
tion and the concomitant inhibition of hGDH isozymes should
be observed. As shown in Fig. 1B, the reactivation of ADP-
ribosylated hGDH isozymes was observed in the presence of




































Fig. 1. Inhibition of hGDH isozymes by ADP-ribosylation and
reactivation of ADP-ribosylated hGDH isozymes by mitochondrial
hydrolase. (A) hGDH isozymes were ADP-ribosylated in the presence
of 100 lMNAD+. Samples were withdrawn at the times indicated and
their activity determined. Results are expressed as a percentage of each
control. The initial speciﬁc activities of hGDH1 and hGDH2 were
108 lmol/mim/mg and 131 lmol/mim/mg, respectively. (s) hGDH1;
(n) hGDH2. (B) hGDH isozymes were ADP-ribosylated by incubating
mitochondria and hGDH isozymes in the presence of 100 lM NAD+
for 60 min. The hGDH isozymes were then centrifuged to remove the
added mitochondria and thereafter (time zero) 5 mM MgCl2 was
added to all samples and incubation continued. Aliquots received
10 mM EDTA and GDH activity was determined. The arrow indicates
re-addition of mitochondria to the sample previously freed of
mitochondria. The data represent three experiments using two diﬀerent
mitochondria preparations. (s) hGDH1; (n) hGDH2.et al. [11], this activity can be designated as ADP-ribosycys-
teine hydrolase. Therefore, the recovery of the activities of
the hGDH isozymes is most likely due to the restoration of
the sulfhydryl group of the modiﬁed cysteine.
Herrero-Yraola et al. [11] have reported the regulation of
GDH by reversible ADP-ribosylation in mitochondria and
proposed an involvement of an active site Cys in the ADP-
ribosylation. It is possible that the modiﬁed Cys is part of
the active site or that it is suﬃciently close that its modiﬁcation
by ADP-ribosylation causes total steric hindrance of the cata-
lytic reaction. We previously reported the loss of GDH activity
following chemical modiﬁcation of Cys323 residue [21]. How-
ever, our very recent studies with site-directed mutagenesis of
Cys323 residue show that Cys323 is not involved in ADP-
ribosylation, although it plays an important role in GDH
activity [22]. To our knowledge, the reactive Cys residue(s) di-
rectly involved in ADP-ribosylation has not been identiﬁed
from any sources of GDHs. In the present work, we have
examined the role of putative Cys residues in the ADP-ribosyl-
ation of hGDH1 and hGDH2.
For some reasons that could not be answered at this mo-
ment, mutant proteins at position of Cys93 and Cys201 were
not properly expressed as determined by Western blot anal-
ysis and could not be puriﬁed (data not shown). Therefore,
no further characterization was performed with the Cys93 or
Cys201 mutants. The mutant proteins at Cys59, Cys119, and
Cys274 site were eﬃciently expressed in E. coli as soluble
proteins. Analysis of crude cell extracts by Western blot
showed that all mutant plasmids encoding three diﬀerent
amino acid substitutions at those Cys sites directed the syn-
thesis of a protein that interacted with monoclonal antibod-
ies raised against bovine GDH at almost identical levels with
wild-type hGDH isozymes (Fig. 2A). The mutant proteins
were also homogeneously puriﬁed by the same method used
for puriﬁcation of wild-type hGDH isozymes (Fig. 2B). The
expressed hGDH2 proteins migrated to just above the
hGDH1 proteins on both Western blot and SDS–PAGE,
as reported elsewhere [7,24].
To investigate the catalytic properties of the mutant en-
zymes, apparent Km values for NADH and a-ketoglutarate
as well as the catalytic eﬃciency for the individual substrates
were compared (Table 1). The kcat values of the mutant pro-
teins decreased 10–25% compared to those of the wild-type
isozymes. For Cys59 mutants, the Km values for NADH
and a-ketoglutarate increased slightly and only minor reduc-
tion was observed for the kcat/Km values. For Cys119 mu-
tants, the Km values increased up to 1.1-fold and 1.6-fold
for NADH and a-ketoglutarate, respectively (Table 1). This
result indicates that substitution at position 119, although
in part, aﬀected the aﬃnity of enzyme for a-ketoglutarate
but not for NADH. Therefore, the 50% decrease in kcat/
Km-a-KG of the Cys119 mutants mainly results from the
increase in Km-a-KG. For Cys274 mutants, the Km values in-
creased up to 2.3-fold for NADH, indicating that substitution
at position 274 aﬀected the aﬃnity of enzyme for NADH,
whereas the Km-a-KG values were not aﬀected by the mutagen-
esis at Cys274 site (Table 1). Since the mutagenesis at Cys274
site has no eﬀects on expression or stability of the Cys274
mutants (Fig. 2A), the 60% reduction in kcat/Km-NADH of
the Cys274 mutants mainly are due to the increase in the Km
values for a-ketoglutarate. In general, there were no big dif-
ferences in the kinetic parameters of the Cys mutants between
Fig. 2. Electrophoretic analysis of wild-type hGDH isozymes and Cys mutants. (A) Western blot analysis of hGDHs in crude extracts of E. coli
expressing hGDH1 or hGDH2. In each lane of this immunoblot, 60 lg of protein from cell extracts were used. (B) SDS–PAGE of puriﬁed proteins.
Lane M, molecular weight marker proteins; lane 1, wild-type hGDH1; lanes 2–10, hGDH1 Cys mutants (C59A, C59G, C59Y, C119A, C119G,
C119Y, C274A, C274G, and C274Y); lane 11, wild-type hGDH2; lanes 12–20, hGDH2 Cys mutants (C59A, C59G, C59Y, C119A, C119G, C119Y,
C274A, C274G, and C274Y).
Table 1
Kinetic parameters of the puriﬁed wild-type and mutant GDHs
Isotype kcat (s
1) Km-NADH (lM) Km-a-KG (mM) kcat/Km-NADH (s
1 lM1) kcat/Km-a-KG (s
1 mM1)
hGDH1
Wild-type 104 81 1.25 1.28 81.3
C59A 90 97 1.40 0.93 64.3
C59G 91 94 1.34 0.97 67.9
C59Y 85 99 1.36 0.86 62.5
C119A 81 90 1.90 0.90 42.6
C119G 77 92 1.94 0.84 39.7
C119Y 79 91 1.86 0.87 42.5
C274A 90 189 1.40 0.48 64.3
C274G 91 181 1.16 0.50 78.4
C274Y 88 178 1.37 0.49 64.2
hGDH2
Wild-type 130 86 1.39 1.51 93.5
C59A 117 99 1.61 1.18 72.7
C59G 110 106 1.67 1.04 65.9
C59Y 108 102 1.58 1.06 68.4
C119A 105 101 2.12 1.04 49.5
C119G 101 98 2.18 1.03 46.3
C119Y 103 108 2.26 0.95 45.6
C274A 114 169 1.59 0.67 71.7
C274G 109 175 1.58 0.62 69.0
C274Y 100 176 1.66 0.57 60.2
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tants in more detail, in particular by rapid-reaction kinetics,
remain to be studied in order to elucidate the role of these
residues more fully.
Among the Cys mutant proteins tested, only Cys119 mu-
tants were not inhibited by ADP-ribosylation (Fig. 3). In con-
trast to the inhibition of the wild-type (Fig. 1A) and the Cys59
and Cys274 mutants by the ADP-ribosylation (Fig. 3A and B),
less than 10% inhibition was observed with Cys119 mutants for
both hGDH1 and hGDH2 (Fig. 3). GDH is catalytically active
as a homohexamer [1]. To establish the stoichiometry between
the enzyme and the ADP-ribose incorporated, the extent of
ADP-ribosylation of highly puriﬁed hGDH isozymes was
examined. The stoichiometry between incorporated ADP-
ribose and GDH subunits shows a modiﬁcation of approxi-
mately one subunit per catalytically active homohexamer(Table 2). Therefore, the inactivation of the hexameric enzyme
by modiﬁcation may be due to the highly cooperative interac-
tions between the subunits and ADP-ribosylation represents
an eﬃcient means of GDH regulation. For both hGDH iso-
zymes, there were no diﬀerences in their sensitivities to ADP-
ribosylation between the wild-type and the Cys59 and
Cys274 mutants (Table 2), suggesting that the Cys59 and
Cys274 residues are not directly involved in the ADP-ribosyl-
ation of hGDH isozymes. In contrast, the dramatic reduction
of the ADP-ribosylation was observed with Cys119 mutants
for both hGDH1 and hGDH2. Taken together with the inhi-
bition studies (Fig. 3), these results suggest that Cys119 residue
plays an important role in the ADP-ribosylation of the hGDH
isozymes.
GDH catalyzes the reversible deamination of L-glutamate to





































Fig. 3. Inhibition of Cys mutants of hGDH isozymes by ADP-
ribosylation. Experimental conditions were the same as in Fig. 1A
except that Cys59, Cys119, and Cys274 mutants were used. Since there
were no diﬀerences in their inhibitory patterns among the substitution
of Cys with Ala, Gly, and Tyr, only results with C59A, C119A, and
C274A are shown for clarity. (A) hGDH1; (B) hGDH2. (d) C59A; (j)
C119A; (n) C274A.
Table 2
Stoichiometry of ADP-ribose incorporation into hGDH isozymes
hGDH1 hGDH2
None (+)ADP (+)GTP None (+)ADP (+)GTP
Wild-type 0.8 0.9 0.8 0.8 0.8 0.8
C59A 0.7 0.8 0.8 0.8 0.7 0.8
C59G 0.8 0.8 0.7 0.7 0.7 0.7
C59Y 0.8 0.8 0.8 0.7 0.8 0.8
C119A 0.2 0.1 0.1 0.1 0.1 0.2
C119G 0.1 0.2 0.2 0.1 0.2 0.1
C119Y 0.2 0.1 0.1 0.2 0.1 0.1
C274A 0.9 0.7 0.8 0.8 0.7 0.8
C274G 0.8 0.8 0.7 0.8 0.8 0.8
C274Y 0.8 0.7 0.8 0.7 0.8 0.7
The enzymes were ADP-ribosylated by adding 1 mg/ml mitochondrial
preparation and 100 lM [32P]NAD+ (10 mCi/ml) in 20 mM Tris–HCl,
pH 8.0 at 25 C in the presence and absence of the allosteric regulators,
ADP or GTP. Final concentrations of ADP and GTP were 1 mM and
0.1 mM, respectively. Samples were subjected to gel ﬁltration by
HPLC. Prior to gel ﬁltration, the samples were made 5 mM in unla-
beled NAD+ to minimize co-migration with GDH of non-covalently
bound radioactive NAD+. The eluting fractions containing GDH were
pooled and both their protein content and bound radioactivity deter-
mined. Data are expressed as the molar ratio of 32P incorporated per
hexameric enzyme and the results were corrected for the data obtained
from samples lacking GDH.
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for the citric acid cycle. Therefore, the GDH activity is strictly
regulated. In addition, glutamate is known as an excitatory
neurotransmitter with neurotoxic potential [31], supportingthe necessity to control its metabolism. GTP has been known
to inhibit GDH activity and enhance NADH substrate inhibi-
tion and ADP also has been known to be an important alloste-
ric activator of GDH activity [1,8,32–34]. The data in Table 2
show the eﬀects of these allosteric regulators on ADP-ribose
incorporation into hGDH isozymes. The incorporation of
[32P]NAD+ was not aﬀected by the presence of ADP or GTP
for both hGDH isozymes. These results suggest that the
ADP-ribosylation is unlikely to occur in allosteric sites in
hGDH isozymes. Rather, our results suggest that the modiﬁca-
tions of hGDH isozymes by ADP-ribosylation at Cys119 site
may induce a conformational change, subsequently causing
an inactivation of the enzyme.
Recent molecular biological studies have conﬁrmed that two
forms of GDH of distinct genetic origin, hGDH1 (house-keep-
ing GDH) and hGDH2 (nerve-speciﬁc GDH), are expressed in
human tissues [6,8]. However, it is not known whether the dis-
tinct properties of the hGDH isozymes are essential for the
regulation of glutamate metabolism and the functional signif-
icance of nerve-speciﬁc GDH isotype in nerve tissue remains to
be studies. hGDH1 is potently inhibited by GTP, whereas
hGDH2 is resistant to this compound [33,34]. This resistance
may permit the nerve tissue-speciﬁc hGDH2 to function in
the GTP-rich environment that prevails in the nervous tissue.
Interestingly, many studies have described mutations aﬀecting
the GTP-binding domain of GDH in children with the hyper-
insulinism-hyperamonemia syndrome [9,35–37]. On the other
hand, hGDH2 is much more sensitive to allosteric activation
by ADP or L-leucine than hGDH1 [33,38]. Therefore, further
characterization of the function and regulation of human
GDH isozymes is needed to elucidate the physiological nature
of the GDH-related disorders. Although the regulation of the
hGDH isozymes to the ADP-ribosylation is not fully under-
stood, our results suggest a possibility that ADP-ribosylation
might complement the allosteric regulations of hGDH iso-
zymes by ADP and GTP.
To our knowledge, this is the ﬁrst report identifying a reac-
tive Cys residue in ADP-ribosylation of hGDH isozymes by
cassette mutagenesis. The exact functional role of Cys119
and the underlying regulatory mechanisms of ADP-ribosyla-
tion in hGDH isozymes would have to be addressed in future
studies.
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